Cao, Shiliang External Entity

Publications

Sort by

Selected publications

  • CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer.  Cell reports. 2016 In Process GET IT
    Times cited: 3

Other